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Purpose. To examine the relationship between the morphological and functional results in eyes after pars plana vitrectomy (PPV)
with internal limiting membrane (ILM) peeling due to stage 4 full-thickness macular hole (FTMH).Methods. -e study included
22 eyes that underwent successful PPV due to FTMH. Both vertical metamorphopsia (VM) and horizontal metamorphopsia (HM)
were determined using type 2 M-charts, as well as best-corrected visual acuity (BCVA), microperimetry, and optical coherence
tomography (OCT) were performed before PPV and 1 and 6months postoperatively. Results. A significant improvement of BCVA
and metamorphopsia scores measured by M-charts in particular periods before surgery, 1 and 6months after PPV, was observed.
-e VM scores were consistently higher than the HM scores at all assessment times. -ere was a correlation found between VM
and BCVA and microperimetry parameters before surgery. -e macular sensitivity (MS) as well as macular integrity index
increased from 1month to 6months after PPV and were correlated with postoperative visual acuity (VA).-ere was a correlation
found between the hole diameter and MS and P2 parameter 6months after PPV. -ere was a correlation found between mean
duration of symptoms of FTMH and VA and VM score. Conclusions. VM scores seem to correlate better than HM scores with
preoperative BCVA, microperimetry parameters, and duration of symptoms of the FTMH. VM scores are higher after PPV than
HM scores in patients with stage 4 of the FTMH. -is trial is registered with NCT03701542.
1. Introduction
-e full-thickness macular hole (FTMH) is a defect in all
layers of the neurosensorial retina including the ana-
tomical area of the fovea with preserved intact retinal
pigment epithelium [1]. FTMH affects mostly elderly
people, more commonly females than males, and the
female-to-male ratio is determined to be 3.3 to 1 [2]. -e
pars plana vitrectomy (PPV) is the most effective pro-
cedure for the treatment of FTMH, with reported closure
rates of first intervention exceeding 90% [3]. -e main
surgical indication for vitrectomy in FTMH is stages 2, 3,
and 4 [4]. -e classical surgical procedure consists of the
central vitreous excision, the internal limiting membrane
(ILM) staining and peeling, intraocular tamponade using
air or expandable gases, and postoperative patient posi-
tioning. A lot of factors have been investigated as potential
predictors of final visual acuity (VA) following surgical
repair of FTMH. Better surgical and functional results are
associated with earlier stage of FTMH, better preoperative
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VA, shorter duration of symptoms, and younger patient
age [5].
In clinical practice to evaluate visual function, the VA
alone is usually used; however, it does not always provide a
complete visual identity. -e Amsler test is very simple,
cheap, and consists of evenly (every 5mm) spaced horizontal
and vertical lines. -e Amsler test is widely used to evaluate
metamorphopsia, but it does not provide quantification of
the severity of metamorphopsia [6]. M-charts (Inami, Japan)
developed in 1999 by Matsumoto et al. enable evaluation of
the degree of metamorphopsia quantitatively in patients
with macular disease [7].
To evaluate the visual function in macular diseases,
microperimetry MAIA can also be used, as it measures
retinal sensitivity of the macular region, and the results can
be displayed over a fundus image [8]. -e microperimetry is
a useful tool for objective evaluation of macular function,
progression of the disease, and effectiveness of therapy [9].
-e purpose of this study was to analyse meta-
morphopsia using the Amsler test and M-charts, as well as
evaluation of macular sensitivity (MS) by using micro-
perimetry, correlation with macular hole diameter, after
successful repair of FTMH.
2. Methods
It was a prospective study of 22 consecutive patients who
underwent successful surgery for FTMH at the Department
of General Ophthalmology in Lublin, Poland. -e study was
performed in accordance with the Declaration of Helsinki.
-e approval of Ethics Committee of the Medical University
of Lublin, Poland, has been given (KE-0254/269/2018). -e
study has been registered at ClinicalTrials.gov under the
number NCT03701542. Written informed consent was
obtained from all patients.
Inclusion criterion was the presentation of FTMH.
Exclusion criteria were as follows: preexisting ocular diseases
that could influence the outcome of the surgery, history of
ocular trauma, and ocular surgery except for cataract sur-
gery. -ere were 19 females and 3 males included in the
study with average age of 66.73± 5.87 years. -e surgeries
were performed under local anesthesia by 2 vitreoretinal
surgeons (KN and RR) using the Constellation system
(Alcon, Fort Worth, Texas, US). -e surgical technique
characterized a standard 3-port 23, 25, or 27 gauge PPV,
internal limiting membrane (ILM) peeling, fluid-air ex-
change, and gas tamponade (20% sulfur hexafluoride-SF6
gas). -e ILM was stained in all eyes with a vital dye Brilliant
Blue G (Geuder, Heidelberg, Germany). ILM was peeled off
with forceps in an area of ≥2 disc diameters around the
FTMH. All eyes were pseudophakic; cataract surgery was
performed by phacoemulsification and implantation of
foldable intraocular lens before FTMH surgery. Patients
were instructed to remain in a prone position for about one
week after the surgery.
Collected preoperative data were as follows: subjective
duration of symptoms and diameter of the FTMH. All
patients underwent best-corrected visual acuity (BCVA) and
best near visual acuity (BNVA) measurements, Amsler test,
M-charts, microperimetry (MAIA CenterVue, Italy), optical
coherence tomography (OCT) examination OCT-2000
(Topcon Corporation, Tokyo, Japan), slit-lamp examina-
tion, and dilated funduscopy. -e patients were examined
before vitrectomy, 1 and 6months after surgery.
BCVA was measured using Snellen decimal charts and
converted into logMAR values. BNVA was measured using
Snellen charts.-e BNVA andM-charts test were performed
with the best near correction, in the same lighting conditions
and from the distance of 30 cm.
-e type 2 M-charts consist of a double 19 dotted line
with increasing dot intervals from 0.2° to 2.0° of visual angle.
-e test is carried out in the vertical and horizontal di-
rections separately. -e M-charts result was considered
positive if the metamorphopsia score was more than 0 [6].
OCT, first introduced in 1995, became the gold standard
in assessment of macular structure. OCT images were used
preoperatively for the confirmation of the diagnosis and for
measuring of the hole diameter and postoperatively for
confirming the closure of the macular hole. Macular hole
diameter was measured in micrometers as the minimum
distance between themargins of FTMH.-e FTMH stage was
classified according to the Gass classification [10]. -ere was
only stage 4 FTMH included. FTMH closure after surgery was
determined with both a slit-lamp examination and OCT.
Microperimetry MAIA examination was performed in a
dark room to analyse the retinal sensitivity and fixation
stability (macular integrity index, P1 and P2 parameters).
-e background luminance was 4 asb, stimulus intensity
range was 0–36 dB, stimulus size was Goldmann III, stim-
ulus duration was 200ms, and testing protocol was 4-2
threshold strategy.
Statistical analysis was performed using STATISTICA
13.0 software (StatSoft, Poland). All values were presented as
the means and medians± standard deviation, and for
nonmeasurable parameters, cardinality and percentage are
used. -e Shapiro–Wilk test analysed measurable parame-
ters. -e Friedman ANOVA test was used to compare the
preoperative and postoperative results. -e R Spearman
correlation was used to evaluate the relationship between the
variables. p< 0.05 was considered to be of statistical
significance.
3. Results
3.1. Visual Acuity. -e mean BCVA before FTMH surgery
was 1.04± 0.40 logMAR. -e mean postoperative BCVA of
all patients after 1month was 0.64± 0.27 logMAR and after
6months was 0.47± 0.22 logMAR (Figure 1). Statistical
analysis showed a significant improvement in the BCVA
after the surgery, and there were also significant differences
in BCVA assessment in particular periods before surgery, at
1 and at 6months after PPV (p< 0.00001).
-e mean diameter of FTMH before vitrectomy was
609.45± 150.45 μm. -e mean duration of symptoms was
12.11± 5.90months.
-ere was no correlation between BCVA before surgery
and patients’ age (p � 0.28), diameter of the FTMH
(p � 1.98), and duration of symptoms (p � 0.61).
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Statistical analysis showed a significant relationship
1month after vitrectomy between BCVA and duration of
symptoms (R� 0.46), which was still significant after
6months (R� 0.47). After 6months, there was also a cor-
relation between BCVA and diameter of the FTMH
(R� 0.46).
-e mean BNVA before surgery was 1.83± 0.68. -e
mean BNVA of all groups was 1.16± 0.47 on 1month and
0.91± 0.49 on 6months. Statistical analysis showed signifi-
cant differences in BNVA before and after successful surgery
(p< 0.00001). Preoperatively, the mean BNVA was signif-
icantly correlated with diameter of the FTMH (R� 0.49). It
means that the higher the diameter of the FTMH, the higher
the BNVA value.
-ere was a correlation found between BCVA before
surgery and 1 and 6months after vitrectomy. It means that
better the BCVA before surgery, better the BCVA results
after surgery.
3.2. Metamorphopsia Scores. -e mean vertical meta-
morphopsia (MVM) score of all patients was 1.11± 0.32
before surgery, improved to 0.85± 0.57 on 1month and
0.86± 0.56 on 6months (Figure 2). Statistical analysis
showed significant differences in the VM score in particular
periods before surgery, 1 and 6months after PPV
(p � 0.002).
-emean horizontal metamorphopsia (MHM) score of
all patients was 1.03 ± 0.38 before surgery, 0.64 ± 0.42 on
1month and 0.65 ± 0.42 on 6months. Statistical analysis
showed significant differences in the HM score in par-
ticular periods before surgery, 1 and 6months after PPV
(p � 0.00002).
-e MVM scores were consistently higher than the
MHM scores at all assessment times. Statistical analysis
showed significant correlation between VM and HM scores,
before surgery (R� 0.69), 1month (R� 0.72), and 6months
(R� 0.83) after PPV.
-ere was a significant correlation between VM scores
and microperimetry parameters before surgery, and no
correlation was found between HM scores and micro-
perimetry parameters (Table 1). No such correlation was
found in regard to HM and VM scores 1 and 6months after
surgery.
Statistical analysis showed significant correlation be-
tween VM score and BCVA before vitrectomy (R� 0.52), but
no such a correlation was found for the HM score. -e
higher the preoperative logMAR value, the higher the VM
score. Statistical analysis did not show significant correlation
between M-score (VM and HM scores) and BCVA after
surgery (p> 0.05), as well as with preoperative diameter of
FTMH at any assessment time (p> 0.05).
-ere was a correlation found between mean duration of
symptoms of FTMH and VA and VM score.
3.3. Microperimetry. Mean macular sensitivity (MS) of all
patients before surgery was 21.18± 2.92 dB, 22.80± 4.37 dB
after 1month, and 24.22± 5.03 dB after 6months after PPV.
Statistical analysis showed significant improvement in the
MS before surgery, 1 and 6months after PPV (p< 0.00001)
(Figure 3).
-e macular integrity index was 95.12± 20.96 before
surgery, 91.10± 15.77 on 1month, and 80.80± 25.74 on
6months after PPV. Statistical analysis showed significant
improvement in the macular integrity index before surgery,
1 and 6months after PPV (p � 0.0009).
Mean fixation stability P1 and P2 values of all patients
were P1� 60.09± 24.06 and P2� 88.73± 11.94 before
MV
MH














Figure 2: Medians, 25 and 75% quartiles, and maximum and
minimum values of metamorphopsia scores both in vertical di-
rection (VM) and horizontal direction (HM).

















Figure 1: Medians, 25 and 75% quartiles, and maximum and
minimum values of the visual acuity (logMAR) before pars plana
vitrectomy (PPV) and after 1 and six months of the follow-up.
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surgery, P1� 63.32± 27.05 and P2� 86.05± 19.71 on
1month, and P1� 65.73± 18.56 and P2� 92.00± 6.12 on
6months after PPV. -ere were no significant differences in
these parameters after statistical analysis.
Statistical analysis did not show significant correlation
between microperimetry and preoperative BCVA (p> 0.05),
while after surgery, there was a correlation between BCVA
and MS (R�−0.64) on 1month and on 6months (R� 0.56)
and between BCVA and macular integrity (R� 0.70) on
1month and (R�−0.48) on 6months.
-ere was a correlation found between FTMH diameter
and MS and P2 parameter 6months after PPV.
4. Discussion
-e current study was performed to assess the functional
characteristics and surgical outcomes using M-charts and
microperimetry in a group of patients with FTMH.
We observed a significant improvement of BCVA and
reduction of metamorphopsia after successful FTMH sur-
gery, which was similar to the previous studies.
Kim et al. investigated the time to visual recovery after
FTMH surgery. -ey observed significant differences in
BCVA at 1 and 3months after PPV, and BCVA stabilized
after 6months [11]. We also observed continuous im-
provement in VA from 1month after PPV to 6months after
the operation. Shinoda et al. reported visual recovery at
3months after MH surgery in a 25-gauge vitrectomy group
and at 9months after surgery in a 20-gauge vitrectomy
group [12]. Mini-invasive surgery provides the shorter
operation time, less trauma to the ocular surface, reduced
amount of irrigation fluid, and is the reason for shorter
recovery time. Directly after PPV, 77.27% of our patients had
better VA results. At final follow-up period, we got the result
of 100% VA improvement. It is a satisfactory outcome
because Leisser et al. had BCVA improved in 83% of the
cases and Amram et al. reported that 86% of eyes had
improved BCVA at the final follow-up period of 1 year
[13, 14]. Although percentage of patients with BCVA im-
provement is very important, it is necessary to estimate the
level of final correction. -e significant improvement of
BCVA (greater than 50%) after 6months we obtained in
50.00% of patients. -e medium BCVA improvement
(≥18%) was in 45.45% eyes, and 4.55% of patients had poor
BCVA result (<18%). We also found the correlation between
preoperative BCVA and 6months after surgery. Better
postoperative VA was correlated with better preoperative
VA (R� 0.46), which was similar to the previous study [15].
Wendel et al. suggested better improvement in VA of
patients undergoing FTMH repair with less than 6months’
duration of visual symptoms [16]. Delay from preoperative
assessment to surgery can be a significant predictor of
outcomes at final follow-up. In our study, duration of visual
symptoms was 12.11± 5.90months. Reasons for delay to
surgery include patient or/and staff scheduling difficulties,
lack of patient-perceived urgency, healthcare system, and
other social factors.
We established lower postoperative BCVA due to larger
diameter of FTMH. It is consistent with the study of Kim
et al. that final visual acuity was poor in patients with a larger
basal hole diameter [11].
Metamorphopsia is a common symptom affecting
quality of vision due to the displacement of the photore-
ceptors and outer segments from their original position [17].
In our study, the Amsler test was abnormal pre-
operatively in 100% of patients, but it does not give the
information about the severity of metamorphopsia. Ninety
percent of our patients after successful surgery reported
distortion of image using the Amsler test; however, the
evaluation of their intensity is also difficult to assess.
In our study, the MVM score of all patients before
surgery was 1.11± 0.32 and the MHM score was 1.03± 0.38.
We observed a significant improvement of these parameters
after surgical repair of macula. -e MVM score 6months
after surgery was 0.86± 0.56, and the MHM score was
0.65± 0.42. Furthermore, the VM scores were consistently
higher than the corresponding HM scores, and there was a
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Figure 3: Medians, 25 and 75% quartiles, and maximum and
minimum values of the following parameters in microperimetry:
average threshold (in decibels), P1 and P2 fixation stability (%), and
macular integrity (in decibels, dB).
Table 1: Correlation between horizontal (HM) and vertical (VM)
M-charts and microperimetry parameters.
Parameters
VM HM
R p R p
Average threshold (dB) −0.47 0.03∗ −0.39 0.08
P1 −0.51 0.02∗ −0.38 0.08
P2 −0.48 0.02∗ −0.35 0.11
Macular integrity −0.02 0.92 0.03 0.90
∗p< 0.05 indicates that significant correlations were found between two
parameters.
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trend—the higher the VM, the higher the HM scores at all
assessment times. It is a similar result to the previous study
[6, 17, 18].
In our study, the major finding was that VM scores seem
to correlate better with preoperative BCVA, microperimetry
parameters, and duration of symptoms of FTMH. VM scores
are also higher after PPV than HM scores in patients with
stage 4 FTMH. Most of the authors [7, 19, 20] present only
general score of M-charts. Wada et al. analyse both HM and
VM scores [6].
-e higher VM score was reported and speculated that
the nasal outer segments had a tendency to be thicker than
other sides in FTMH, since the greater stretching of
tissues toward the thicker retinal regions. -e larger
horizontal retinal changes may be due to the higher VM
score [17].
Arimura et al. believed that the VM score was correlated
with the horizontal retinal contraction and the HM score
was correlated with the vertical retinal contraction [18].
Liang et al. also found that the VM score was signifi-
cantly higher than the HM score, they concluded the reason
behind the asymmetrically elongation, and the higher VM
score remains to be further studied. Liang et al. also re-
ported the relationship between M-score and macular
parameters. -ey found that the postoperative mean
M-score was significantly positively correlated with the
mean minimal diameter of FTMH, but there was no
correlation between preoperative M-score and the mean
minimal diameter. Furthermore, they proposed that the
mean minimal diameter of FTMH may be a prognostic
factor for postoperative metamorphopsia, which may help
one to predict postoperative metamorphopsia before sur-
gery [17]. Our results contrast with this study, because we
did not find any correlation betweenM-scores and minimal
diameter of FTMH. Also, the other researchers showed no
significant correlations between the VM and HM scores
and any of the preoperative OCT parameters at any as-
sessment time [6, 19]. It may reflect a difference in the
average minimum diameter of the FTMH in different study
populations. In addition, in our study, there was a sig-
nificant correlation between preoperative VM score and
BCVA. We agree with the other researchers that pre-
operative metamorphopsia measured by M-charts may
have more complicated affected factors besides macular
parameters and evaluating M-scores, especially VM score
in addition to BCVA can be an independent treatment
outcome [6, 17].
To assess the functional success of the surgery, we used
microperimetry measuring retinal sensitivity and the fixation
behavior while fundus is directly examined. It is rapid, safe,
noninvasive, and useful tool for evaluation of macular
function [9]. We observed preoperatively a significant loss of
sensitivity of macular area affected by a disease, and the mean
sensitivity (dB) was 21.18± 2.92. Six months after surgery, the
mean sensitivity was better (24.22± 5.03). -e macular in-
tegrity index is a numerical value that describes the likelihood
that a patient’s responses are normal, suspect, or abnormal
when compared to age-adjusted normative data. It does not
represent the severity of the disease process. -ere is no direct
relationship between the average threshold value (dB) and the
macular integrity index. Preoperatively, in our group, the
mean macular integrity index was 95.12± 20.96 and 6months
after surgery was 80.80± 25.74. -e lower value of the
macular integrity index means the better respond and
postoperative improvement of this parameter. We found the
correlation between the postoperative mean MS and the
preoperative size of FTMH. -e larger diameter of FTMH
provides the lower value of MS. -e higher MS and lower
macular integrity index are correlated with better post-
operative BCVA. Our results and connections between MS
and diameter of FTMH or MS and quality of postoperative
BCVA are similar to the result previously shown by Bonnabel
et al. [15]. It needs to be highlighted that, we did not find any
significant correlation between MS and preoperative BCVA
(p> 0.05), somicroperimetry can be an additional, useful tool
in predicting the postoperative prognosis and objective
evaluation of changes in visual outcome. Additionally, we
found correlation between microperimetry and M-score
before PPV. Parameters such as average threshold value, P1,
and P2, were correlated with the VM score. -ere were no
similar connections with the HM score (p> 0.05). -e lower
VM score provides the better MS, P1, and P2 results.
Preoperative, intraoperative, and postoperative factors
have been investigated as potential predictors of final VA
following surgical repair of FTMH. Among preoperative
factors, two well established are symptom duration and
preoperative VA. -e other factors are patient age and OCT
parameters such as stage of FTMH, minimum diameter or/
and base diameter of the FTMH, central subfield retinal
thickness, height of the FTMH and diameter of internal/
external segments layer IS/OS, and external limiting
membrane (ELM) defects [5, 21, 22]. However, these pa-
rameters are anatomical, imaging-based features, and to
estimate the result of FTMH surgery, functional tests are
required too.
In summary, this study evaluated prospectively meta-
morphopsia using M-charts and Amsler test, and MS result
in microperimetry MAIA among patients after successful
vitrectomy due to FTMH. Both microperimetry and
M-charts test, especially VM-score, provide more compre-
hensive information of the visual function of FTMH patients
before and after surgery and can be useful, additional
predictor factors of succeed vitrectomy and postoperative
results.
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